Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: To combat invading pathogens, cells develop an adaptive immune response by changing their own genetic information. In vertebrates, the generation of genetic variation (somatic hypermutation) is an essential process for diversification and affinity maturation of antibodies that function to detect and sequester various foreign biomolecules. The activation-induced cytidine deaminase (AID) carries out hypermutation by modifying deoxycytidine bases in the variable region of the immunoglobulin locus that produces antibody. AID-generated deoxyuridine in DNA is mutagenic as it can be miss-recognized as deoxythymine, resulting in C to T mutations. CRISPR (clustered regularly interspaced short palindromic repeats)/Cas (CRISPR-associated) is a prokaryotic adaptive immune system that records and degrades invasive foreign DNA or RNA. The CRISPR/Cas system cleaves and incorporates foreign DNA/RNA segments into the genomic region called the CRISPR array. The CRISPR array is transcribed to produce crispr-RNA that serves as guide RNA (gRNA) for recognition of the complementary foreign DNA/RNA in a ribonucleoprotein complex with Cas proteins, which degrade the target. The CRISPR/Cas system has been repurposed as a powerful genome editing tool, because it can be programmed to cleave specific DNA sequence by providing custom gRNAs. RATIONALE: Although the precise mechanism by which AID specifically mutates the immunoglobulin locus remains elusive, targeting of AID activity is facilitated by the formation of a single-stranded DNA region, such as a transcriptional RNA/DNA hybrid (R-loop). The CRISPR/Cas system can be engineered to be nuclease-inactive. The nuclease-inactive form is capable of unfolding the DNA double strand in a protospacer adjacent motif (PAM) sequence-dependent manner so that the gRNA binds to complementary target DNA strand and forms an R-loop. The nuclease-deficient CRISPR/Cas system may serve as a suitable DNA-targeting module for AID to catalyze site-specific mutagenesis. RESULTS: To determine whether AID activity can be specifically targeted by the CRISPR/Cas system, we combined dCas9 (a nuclease-deficient mutant of Cas9) from Streptococcus pyogenes and an AID ortholog, PmCDA1 from sea lamprey, to form a synthetic complex (Target-AID) by either engineering a fusion between the two proteins or attaching a SH3 (Src 3 homology) domain to the C terminus of dCas9 and a SHL (SH3 interaction ligand) to the C terminus of PmCDA1. Both of these complexes performed highly efficient site-directed mutagenesis. The mutational spectrum was analyzed in yeast and demonstrated that point mutations were dominantly induced at cytosines within the range of three to five bases surrounding the –18 position upstream of the PAM sequence on the noncomplementary strand to gRNA. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced in the Target-AID complexes. Combination of PmCDA1 with the nickase Cas9(D10A) mutant, which retains cleavage activity for noncomplementary single-stranded DNA, was more efficient in yeast but also induced deletions as well as point mutations in mammalian cells. Addition of the uracil DNA glycosylase inhibitor protein, which blocks the initial step of the uracil base excision repair pathway, suppressed collateral deletions and further improved targeting efficiency. Potential off-target effects were assessed by whole-genome sequencing of yeast as well as deep sequencing of mammalian cells for regions that contain mismatched target sequences. These results showed that off-target effects were comparable to those of conventional CRISPR/Cas systems, with a reduced risk of indel formation. CONCLUSION: By expanding the genome editing potential of the CRISPR/Cas9 system by deaminase-mediated hypermutation, Target-AID demonstrated a very narrow range of targeted nucleotide substitution without the use of template DNA. Nickase Cas9 and uracil DNA glycosylase inhibitor protein can be used to boost the targeting efficiency. The reduced cytotoxicity will be beneficial for use in cells that are sensitive to artificial nucleases. Use of other types of nucleotide-modifying enzymes and/or other CRISPR-related systems with different PAM requirements will expand our genome-editing repertoire and capacity. A crippled CRISPR/Cas targets AID.: In vertebrate adaptive immunity, cytosine deaminase (AID or PmCDA1) induces somatic hypermutation at single-stranded DNA regions formed during transcription. The bacterial CRISPR/Cas9 immunity system recognizes and cleaves invasive DNA in a gRNA-dependent manner. AID and nuclease-deficient CRISPR/Cas9 are engineered to form a hybrid complex (Target-AID) that performs programmable cytosine mutations in a range of a few bases surrounding the –18 position upstream of PAM sequence of the noncomplementary DNA strand.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [26]
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y., & Honjo, T. (2000) · Cell · doi:10.1016/s0092-8674(00)00078-7 · Cited by 3,474
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems
DiCarlo, J. E., Norville, J. E., Mali, P., Rios, X., Aach, J., & Church, G. M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt135 · Cited by 1,566
Synthetic protein scaffolds provide modular control over metabolic flux
Dueber, J. E., Wu, G. C., Malmirchegini, G. R., Moon, T. S., Petzold, C. J., Ullal, A. V., Prather, K. L. J., & Keasling, J. D. (2009) · Nature Biotechnology · doi:10.1038/nbt.1557 · Cited by 1,242
Cas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Cited by
Items 601–700 of 1,001
Improving the Precision of Base Editing by Bubble Hairpin Single Guide RNA
Hu, Z., Wang, Y., Liu, Q., Qiu, Y., Zhong, Z., Li, K., Li, W., Deng, Z., & Sun, Y. (2021) · mBio · doi:10.1128/mbio.00342-21 · Cited by 25
Precision engineering of the probiotic Escherichia coli Nissle 1917 with prime editing
Chen, P.-R., Wei, Y., Li, X., Yu, H., Wang, S., Yuan, X.-Z., & Xia, P. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.00031-25 · Cited by 25
Musolino, P. L., Rosser, S. J., Brittan, M., Newby, D. E., Berry, C., Riley, P. R., Giacca, M., Hajjar, R. J., & Baker, A. H. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf109 · Cited by 26
Bhakta, S., Sakari, M., & Tsukahara, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-74374-5 · Cited by 21
RetractedAn unbiased method for evaluating the genome-wide specificity of base editors in rice
Jin, S., Gao, Q., & Gao, C. (2020) · Nature Protocols · doi:10.1038/s41596-020-00423-y · Cited by 24
Interrogating immune cells and cancer with CRISPR-Cas9
Buquicchio, F. A., & Satpathy, A. T. (2021) · Trends in Immunology · doi:10.1016/j.it.2021.03.003 · Cited by 21
Base Editing in Peanut Using CRISPR/nCas9
Neelakandan, A. K., Subedi, B., Traore, S. M., Binagwa, P. H., Wright, D. A., & He, G. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.901444 · Cited by 22
Zhou, W., Yang, J., Zhang, Y., Hu, X., & Wang, W. (2022) · MedComm · doi:10.1002/mco2.155 · Cited by 31
TadA orthologs enable both cytosine and adenine editing of base editors
Zhang, S., Yuan, B., Cao, J., Song, L., Chen, J., Qiu, J., Qiu, Z., Zhao, X., Chen, J., & Cheng, T. (2023) · Nature Communications · doi:10.1038/s41467-023-36003-3 · Cited by 26
CRISPR Editing Technology in Biological and Biomedical Investigation
White, M. K., Kaminski, R., Young, W., Roehm, P. C., & Khalili, K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26099 · Cited by 27
Mapping a diversity of genetic interactions in yeast
van Leeuwen, J. S., Boone, C. M., & Andrews, B. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.08.002 · Cited by 27
Shelake, R. M., Pramanik, D., & Kim, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031145 · Cited by 22
Greiner-Tollersrud, O. K., Krausz, M., Boehler, V., Polyzou, A., Seidl, M., Spahiu, A., Abdullah, Z., Andryka, K., Dominick, F. I., Hübscher, K., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114899 · Cited by 21
Petri, K., D’Ippolito, E., Künkele, A., Koehl, U., Busch, D. H., Einsele, H., & Hudecek, M. (2025) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-025-01072-4 · Cited by 36
Advances in engineering CRISPR-Cas9 as a molecular Swiss Army knife
Meaker, G. A., Hair, E. J., & Gorochowski, T. E. (2020) · Synthetic Biology · doi:10.1093/synbio/ysaa021 · Cited by 24
Asano, Y., Yamashita, K., Hasegawa, A., Ogasawara, T., Iriki, H., & Muramoto, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-89546-0 · Cited by 24
Highly Efficient CRISPR-Mediated Base Editing in Sinorhizobium meliloti
Wang, L., Xiao, Y., Wei, X., Pan, J., & Duanmu, D. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.686008 · Cited by 25
Yoo, K. W., Yadav, M., Song, Q., Atala, A., & Lu, B. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac186 · Cited by 22
A streamlined guide RNA screening system for genome editing in Sorghum bicolor
Lee, J. S., Bae, S., Kim, J., Kim, C., & Kang, B. (2023) · Plant Methods · doi:10.1186/s13007-023-01058-2 · Cited by 25
Progress in Gene Editing and Metabolic Regulation of Saccharomyces cerevisiae with CRISPR/Cas9 Tools
Liang, Y., Gao, S., Qi, X., Valentovich, L. N., & An, Y. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00685 · Cited by 21
CRISPR/Cas9-mediated genome editing in sea urchins
Lin, C.-Y., Oulhen, N., Wessel, G. M., & Su, Y. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.10.004 · Cited by 22
Plant DNA Repair Pathways and Their Applications in Genome Engineering
Que, Q., Chen, Y., Kelliher, T., Skibbe, D. S., Dong, S., & Chilton, M.-D. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-8991-1_1 · Cited by 25
An aurora of natural products-based drug discovery is coming
Tong, Y., & Deng, Z. (2020) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2020.05.003 · Cited by 21
Kashojiya, S., Lu, Y., Takayama, M., Komatsu, H., Minh, L. H. T., Nishida, K., Shirasawa, K., Miura, K., Nonaka, S., Masuda, J.-I., et al. (2022) · Horticulture Research · doi:10.1093/hr/uhab004 · Cited by 21
Self-citationDomain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope
Bamidele, N., Zhang, H., Dong, X., Cheng, H., Gaston, N., Feinzig, H., Cao, H., Kelly, K. L., Watts, J. K., Xie, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45763-5 · Cited by 26
CRISPR/Cas system-mediated base editing in crops: recent developments and future prospects
Hillary, V. E., & Ceasar, S. A. (2024) · Plant Cell Reports · doi:10.1007/s00299-024-03346-0 · Cited by 25
CRISPR-Hybrid: A CRISPR-Mediated Intracellular Directed Evolution Platform for RNA Aptamers
Su-Tobon, Q., Fan, J., Goldstein, M., Feeney, K. A., Ren, H., Autissier, P., Wang, P., Huang, Y., Mohanty, U., & Niu, J. (2025) · Nature Communications · doi:10.1038/s41467-025-55957-0 · Cited by 22
Research progress of base editing and prime editing tools based on the CRISPR/Cas system
Gao, H., Gao, S., Kan, G., Valentovich, L. N., & An, Y. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102771 · Cited by 29
Chen, D., Lv, X., Li, J., Liu, Y., Du, G., & Liu, L. (2020) · Metabolic Engineering Communications · doi:10.1016/j.mec.2020.e00135 · Cited by 22
Ito, Y., Ishigami, M., Terai, G., Nakamura, Y., Hashiba, N., Nishi, T., Nakazawa, H., Hasunuma, T., Asai, K., Umetsu, M., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-03475-w · Cited by 19
Self-citationTargeted dual base editing with Campylobacter jejuni Cas9 by single AAV-mediated delivery
Kweon, J., Jang, A.-H., Kwon, E., Kim, U. G., Shin, H. R., See, J.-E., Jang, G., Lee, C., Koo, T., Kim, S., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00938-w · Cited by 21
Advances in CRISPR/Cas gene therapy for inborn errors of immunity
Liu, X., Li, G., Liu, Y., Zhou, F., Huang, X., & Li, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1111777 · Cited by 28
Giner, G., Ikram, S., Herold, M. J., & Papenfuss, A. T. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad205 · Cited by 23
CRISPR genetic toolkits of classical food microorganisms: Current state and future prospects
Lv, X., Li, Y., Xiu, X., Liao, C., Xu, Y., Liu, Y., Li, J., Du, G., & Liu, L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108261 · Cited by 21
Beller, Z. W., Wesener, D. A., Seebeck, T., Guruge, J. L., Byrne, A. E., Henrissat, S., Terrapon, N., Henrissat, B., Rodionov, D. A., Osterman, A. L., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2311422120 · Cited by 26
Engineered cytosine base editor enabling broad-scope and high-fidelity gene editing in Streptomyces
Wang, J., Wang, K., Deng, Z., Zhong, Z., Sun, G., Mei, Q., Zhou, F., Deng, Z., & Sun, Y. (2024) · Nature Communications · doi:10.1038/s41467-024-49987-3 · Cited by 21
Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system
Shi, Z., Xin, H., Tian, D., Lian, J., Wang, J., Liu, G., Ran, R., Shi, S., Zhang, Z., Shi, Y., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802661r · Cited by 22
Smith, A. J. P., Deloukas, P., & Munroe, P. B. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00028.2018 · Cited by 21
Lee, K. Y., Lee, H. J., Choi, H. J., Han, S. T., Lee, K. H., Park, K. J., Park, J. S., Jung, K. M., Kim, Y. M., Han, H. J., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001065rrr · Cited by 21
Gong, G., Zhang, Y., Wang, Z., Liu, L., Shi, S., Siewers, V., Yuan, Q., Nielsen, J., Zhang, X., & Liu, Z. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00560 · Cited by 22
Herbicide tolerance-assisted multiplex targeted nucleotide substitution in rice
Shimatani, Z., Fujikura, U., Ishii, H., Terada, R., Nishida, K., & Kondo, A. (2018) · Data in Brief · doi:10.1016/j.dib.2018.08.124 · Cited by 20
Self-citationGenome Editing of Veterinary Relevant Mycoplasmas Using a CRISPR-Cas Base Editor System
Ipoutcha, T., Rideau, F., Gourgues, G., Arfi, Y., Lartigue, C., Blanchard, A., & Sirand-Pugnet, P. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.00996-22 · Cited by 19
“norvegicus (26) and pmcDA1 from Petromyzan marinus (26, 27) (Fig.”
BackgroundGenome editing in cancer: Challenges and potential opportunities
Breier, D., & Peer, D. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.08.013 · Cited by 24
Multiplexed engineering and precision gene editing in cellular immunotherapy
Biederstädt, A., Manzar, G. S., & Daher, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1063303 · Cited by 20
Therapeutic gene correction for Lesch-Nyhan syndrome using CRISPR-mediated base and prime editing
Jang, G., Shin, H. R., Do, H., Kweon, J., Hwang, S., Kim, S.-Y., Heo, S. H., Kim, Y., & Lee, B. H. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.02.009 · Cited by 20
Advancing CRISPR/Cas gene editing with machine learning
Fong, J. H. C., & Wong, A. S. L. (2023) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2023.100477 · Cited by 23
Raper, A. T., Stephenson, A. A., & Suo, Z. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b05469 · Cited by 20
Double Selection Enhances the Efficiency of Target-AID and Cas9-Based Genome Editing in Yeast
Després, P. C., Dubé, A. K., Nielly‐Thibault, L., Yachie, N., & Landry, C. R. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200461 · Cited by 21
Self-citationBlossom of CRISPR technologies and applications in disease treatment
Liu, H., Wang, L., & Luo, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.10.003 · Cited by 21
Data Mining by Pluralistic Approach on CRISPR Gene Editing in Plants
Kaul, T., Raman, N. M., Eswaran, M., Thangaraj, A., Verma, R., Sony, S. K., Sathelly, K., Kaul, R., Yadava, P., & Agrawal, P. K. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00801 · Cited by 19
Double-Check Base Editing for Efficient A to G Conversions
Xin, X., Li, J., Zhao, D., Li, S., Xie, Q., Li, Z., Fan, F., Bi, C., & Zhang, X. (2019) · ACS Synthetic Biology · doi:10.1021/acssynbio.9b00284 · Cited by 20
Murakami, Y., Futamata, R., Horibe, T., Ueda, K., & Kinoshita, M. (2020) · Development Growth & Differentiation · doi:10.1111/dgd.12700 · Cited by 19
CRISPR genome engineering for retinal diseases
Kantor, A., McClements, M. E., Peddle, C. F., Fry, L. E., Salman, A., Cehajic-Kapetanovic, J., Xue, K., & MacLaren, R. E. (2021) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2021.01.024 · Cited by 19
High-precision cytosine base editors by evolving nucleic-acid-recognition hotspots in deaminase
Wu, Y., Xiao, Y., & Tang, W. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02678-w · Cited by 24
Single‐nucleotide editing: From principle, optimization to application
Tang, J., Lee, T., & Sun, T. (2019) · Human Mutation · doi:10.1002/humu.23819 · Cited by 18
Development and Characterization of a Modular CRISPR and RNA Aptamer Mediated Base Editing System
Collantes, J. C., Tan, V. M., Xu, H., Ruiz-Urigüen, M., Alasadi, A., Guo, J., Tao, H., Su, C., Tyc, K. M., Selmi, T., et al. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0035 · Cited by 18
Ding, X.-Y., Li, S., Geng, Y., Yan, M., Li, G., Zhang, G., & Sun, Y. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.734436 · Cited by 20
Li, M., Huo, Y., & Guo, S. (2022) · Biology · doi:10.3390/biology11040571 · Cited by 20
Internally inlaid SaCas9 base editors enable window specific base editing
Jiang, L., Long, J., Yang, Y., Zhou, L., Su, J., Qin, F., Tang, W., Tao, R. X., Chen, Q., & Yao, S. (2022) · Theranostics · doi:10.7150/thno.70869 · Cited by 18
Precise genome editing with base editors
Liu, H., Zhu, Y., Li, M., & Gu, Z. (2023) · Medical Review · doi:10.1515/mr-2022-0044 · Cited by 24
Practical Approaches for the Yeast Saccharomyces cerevisiae Genome Modification
Stepchenkova, E. I., Zadorsky, S. P., Shumega, A. R., & Aksenova, A. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511960 · Cited by 20
Modeling Cancer in the CRISPR Era
Ventura, A., & Dow, L. E. (2017) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050455 · Cited by 18
Flajnik, M. F. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800965 · Cited by 21
Iriki, H., Kawata, T., & Muramoto, T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224128 · Cited by 18
Rabinowitz, R., Abadi, S., Almog, S., & Offen, D. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa215 · Cited by 18
Base editing the mammalian genome
Schatoff, E. M., Zafra, M. P., & Dow, L. E. (2019) · Methods · doi:10.1016/j.ymeth.2019.02.022 · Cited by 28
Base editing in Streptomyces with Cas9-deaminase fusionsPreprint
Zhong, Z., Guo, J., Deng, L., Chen, L., Wang, J., Li, S., Xu, W. Q., Deng, Z., & Sun, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/630137 · Cited by 19
Cytosine base editing in cyanobacteria by repressing archaic Type IV uracil‐DNA glycosylase
Lee, M., Heo, Y. B., & Woo, H. M. (2023) · The Plant Journal · doi:10.1111/tpj.16074 · Cited by 15
Heo, Y. B., Hwang, G., Kang, S. W., Bae, S., & Woo, H. M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.03760-22 · Cited by 19
Developing a Base Editing System for Marine Roseobacter Clade Bacteria
Wei, Y., Feng, L., Yuan, X.-Z., Wang, S., & Xia, P. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00259 · Cited by 19
Huang, Z., Chen, X., Liu, D., Cui, Y., Li, B., & Yuan, Y. (2023) · Biotechnology Journal · doi:10.1002/biot.202300137 · Cited by 20
Doll, R. M., Boutros, M., & Port, F. (2023) · Science Advances · doi:10.1126/sciadv.adj1568 · Cited by 18
Engineered deaminases as a key component of DNA and RNA editing tools
Budzko, L., Hoffa-Sobiech, K., Jackowiak, P., & Figlerowicz, M. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102062 · Cited by 22
CRISPR/Cas9-mediated base editors and their prospects for mitochondrial genome engineering
Eghbalsaied, S., Lawler, C., Petersen, B., Hajiyev, R. A., Bischoff, S. R., & Frankenberg, S. (2024) · Gene Therapy · doi:10.1038/s41434-023-00434-w · Cited by 20
You, Y., Lei, W., Yang, J., Wei, Y., Zhao, Z., Zhao, Z.-A., & Hu, S. (2017) · Gene · doi:10.1016/j.gene.2017.10.078 · Cited by 18
‘Artificial spermatid’-mediated genome editing†
Wang, L., & Li, J. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz087 · Cited by 16
DNA event recorders send past information of cells to the time of observation
Ishiguro, S., Mori, H., & Yachie, N. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.05.009 · Cited by 19
Self-citationKawai, K., Negoro, R., Ichikawa, M., Yamashita, T., Deguchi, S., Harada, K., Hirata, K., Takayama, K., & Mizuguchi, H. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.008 · Cited by 18
Recent advances in CRISPR technologies for genome editing
Song, M., & Koo, T. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01336-4 · Cited by 18
Splice-switching as cancer therapy
Jbara, A., Siegfried, Z., & Karni, R. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.05.008 · Cited by 17
Perfecting Targeting in CRISPR
Zhang, H., Li, T., Sun, Y., & Yang, H. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-030438 · Cited by 19
Base-edited cynomolgus monkeys mimic core symptoms of STXBP1 encephalopathy
Lu, Z., He, S., Jiang, J., Zhuang, L., Wang, Y., Yang, G., Jiang, X., Nie, Y., Fu, J., Zhang, X., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.03.001 · Cited by 19
Double nicking by RNA-directed Cascade-nCas3 for high-efficiency large-scale genome engineering
Hao, Y., Wang, Q., Li, J., Yang, S., Ma, L., Zheng, Y., & Peng, W. (2022) · Open Biology · doi:10.1098/rsob.210241 · Cited by 17
Development of a genetic sensor that eliminates p53 deficient cells
Mircetic, J., Dietrich, A., Paszkowski‐Rogacz, M., Krause, M., & Buchholz, F. (2017) · Nature Communications · doi:10.1038/s41467-017-01688-w · Cited by 18
Programmable RNA writing with trans-splicingPreprint
Schmitt-Ulms, C., Kayabölen, A., Manero-Carranza, M., Zhou, N., Donnelly, K. A., Nuccio, S. P., Kato, K., Nishimasu, H., Gootenberg, J. S., & Abudayyeh, O. O. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.31.578223 · Cited by 21
Current advances in CRISPR-Cas-mediated gene editing and regulation in cyanobacteria
Dong, Z., Chen, L., Wang, Y., Sun, T., & Zhang, W. (2024) · Blue Biotechnology · doi:10.1186/s44315-024-00009-3 · Cited by 16
“For example, in Escherichia coli , primarily C → A results are produced, while in mammalian cells, primarily C → G results are observed, showing considerable randomness [55, 56].”
BackgroundDiscovering weak signals of emerging topics with a triple-dimensional framework
Ma, M., Mao, J., & Li, G. (2024) · Information Processing & Management · doi:10.1016/j.ipm.2024.103793 · Cited by 19
Advances in improving tomato fruit quality by gene editing
Yuan, L., Gai, W.-X., Xuan, X., Ahiakpa, J. K., Li, F., Ge, P., Zhang, X., Tao, J., Yang, Y., & Zhang, Y. (2024) · Horticultural Plant Journal · doi:10.1016/j.hpj.2024.04.008 · Cited by 30
Genome scale analysis of pathogenic variants targetable for single base editing
Лавров, А. В., Varenikov, G. G., & Skoblov, M. Y. (2020) · BMC Medical Genomics · doi:10.1186/s12920-020-00735-8 · Cited by 19
Advances in microbial engineering for the production of value-added products in a biorefinery
Gao, C., Guo, L., Song, W., Wu, J., Chen, X., & Liu, L. (2022) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-022-00104-9 · Cited by 16
Li, G., Cheng, Y., Li, Y., Ma, H., Pu, Z., Li, S., Zhao, Y., Huang, X., & Yao, Y. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.12.001 · Cited by 16
Methods of crop improvement and applications towards fortifying food security
Patel, A., Miles, A., Strackhouse, T., Cook, L., Leng, S., Patel, S., Klinger, K., Rudrabhatla, S. V., & Potlakayala, S. D. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1171969 · Cited by 21
Targeted mRNA demethylation in Arabidopsis using plant m6A editor
Fang, R., Chen, X., Ying, D., Shen, J., & Wang, B. (2023) · Plant Methods · doi:10.1186/s13007-023-01053-7 · Cited by 16
Targeted C-to-T and A-to-G dual mutagenesis system for RhtA transporter in vivo evolution
Wei, Z., Zhao, D., Wang, J., Li, J., Xu, N., Ding, C., Liu, J., Li, S., Zhang, C., Bi, C., et al. (2023) · Applied and Environmental Microbiology · doi:10.1128/aem.00752-23 · Cited by 16
Zhou, C., Okuno, M., Nakazato, I., Tsutsumi, N., & Arimura, S. (2023) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiad678 · Cited by 20
CRISPR/Cas9 as a Mutagenic Factor
Shumega, A. R., Pavlov, Y. I., Chirinskaite, A. V., Rubel, A. A., Inge-Vechtomov, S. G., & Stepchenkova, E. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020823 · Cited by 18
Targeted C•G-to-T•A base editing with TALE-cytosine deaminases in plants
Zhang, D., Pries, V., & Boch, J. (2024) · BMC Biology · doi:10.1186/s12915-024-01895-0 · Cited by 18
Yuan, Y., Liu, S.-Z., Farhab, M., Lv, M.-Y., Zhang, T., & Cao, S.-X. (2024) · Functional & Integrative Genomics · doi:10.1007/s10142-024-01364-5 · Cited by 21
Zhang, Y., Liu, Y., Qin, W., Zheng, S., Xia, X., Xia, X., Yuan, X., Zeng, J., Shi, Y., Zhang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53735-y · Cited by 18
Xin, B., Liu, J., Li, J., Peng, Z., Gan, X., Zhang, Y., & Zhong, C. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.02455-24 · Cited by 23
Metadata
- Authors
- Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., Shimatani, Z., & Kondo, A.
- Affiliations
- Kobe University (JP)
- Keio University (JP)
- Shizuoka University (JP)
- Corresponding author
- Kondo, Akihiko
- ORCID
- Venue
- Science
- Published
- 2016-09-16
- Volume
- 353
- Issue
- 6305
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2480829753
- Cited by
- 1,349
- References
- 27
- Citations by year
- 2026: 69 · 2025: 124 · 2024: 151 · 2023: 152 · 2022: 181 · 2021: 157 · 2020: 167 · 2019: 137 · 2018: 112 · 2017: 88 · 2016: 10
- FWCI
- 60.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports and Technology (MEXT) of Japan
- Ministry of Economy, Trade and Industry (METI), Japan
- JSPS KAKENHI (26119710, 16K14654)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- activation-induced cytidine deaminase, CRISPR/Cas9, dCas9, sea lamprey, somatic hypermutation, R-loops, site-directed mutagenesis, genome editing, immunoglobulin variable region, affinity maturation
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, AICDA (Activation-Induced Cytidine Deaminase), Alleles, Animals, Bacteria, Bacterial Proteins, Cricetulus, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, Endonucleases, Enzyme Inhibitors, Immune System, RNA, Saccharomyces cerevisiae, Vertebrates, CHO Cells, Point Mutation, Gene Targeting, Uracil-DNA Glycosidase, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.